India’s CDSCO Drafts Compensation Formula For Clinical Trial Participants
This article was originally published in PharmAsia News
Executive Summary
India’s agency for drug standards said it has developed a formula for figuring the compensation pharmaceutical companies must make to injured trial participants or families of those who died as a result of the tests.